Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
B. Jouleh (Bergen, Norway), R. Nielsen (Bergen, Norway), P. Bakke (Bergen, Norway), R. Sandvik (Bergen, Norway), T. Kalananthan (Bergen, Norway), J. Ward (Southampton, United Kingdom), S. Wilson (Southampton, United Kingdom), T. Eagan (Bergen, Norway). Bronchial wall inflammatory cells and signs of remodeling in COPD and asthma. 4089

Member's Comments

No comment yet.

Related content which might interest you: Inflammatory cells and airway remodelling in COPD Source: International Congress 2019 – It takes two to tango: translating scientific findings into clinical applications Year: 2019 Airway inflammatory mediators and airway wall remodelling in asthma Source: Annual Congress 2009 - Persistent asthma: still an uncontrolled disease requiring new treatments strategies in 2009 Year: 2009 Bronchial reversibility and airway inflammation in patients with COPD Source: Eur Respir J 2003; 22: Suppl. 45, 436s Year: 2003 Parameters associated with persistent airflow obstruction in chronic severe asthma Source: Eur Respir J 2004; 24: 122-128 Year: 2004 Airway remodelling is present in children with asthma regardless of eosinophilic inflammation Source: Annual Congress 2009 - Novel mechanisms in the pathogenesis of asthma Year: 2009 Pulmonary vascular remodelling in COPD versus bronchial asthma Source: Eur Respir J 2003; 22: Suppl. 45, 82s Year: 2003 Airway epithelial inflammatory responses and clinical parameters in COPD Source: Eur Respir J 2003; 22: 94-99 Year: 2003 Effect of bronchial neutrophilia on airway remodeling in asthma Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair Year: 2019 Inflammatory mediators in eosinophilic COPD phenotype and asthma with fixed airflow obstruction Source: International Congress 2018 – Understanding the immunopathology that underlies airway obstructive diseases Year: 2018 Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD Source: Eur Respir J 2012; 40: 1098-1105 Year: 2012 Eosinophilic airway inflammation in COPD and asthma Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation Year: 2008 Airway remodelling in asthma is related to particular characteristics of airway inflammation Source: Eur Respir J 2002; 20: Suppl. 38, 188s Year: 2002 Increased arginase activity contributes to airway remodelling in chronic allergic asthma Source: Eur Respir J 2011; 38: 318-328 Year: 2011 Osteopontin exacerbates airway hyperresponsiveness and lung remodeling in chronic asthma Source: Annual Congress 2008 - Basic science in asthma and COPD Year: 2008 Inflammatory cell phenotypes in bronchial asthma Source: Eur Respir J 2005; 26: Suppl. 49, 484s Year: 2005 Airway remodelling and TGFβ signalling in children with eosinophilic and non-eosinophilic asthma Source: Annual Congress 2010 - Mechanisms of asthma and lung inflammation Year: 2010 Galectn-3 : marker of airway inflammation in bronchial asthma Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD Year: 2018